Autopsy report · NCT02449161

The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates

“Missing fund to continue”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 5 years 9 months before it stopped.
• 60 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Guy Waddell

Sponsor type

University, hospital or other

Conditions

Menorrhagia

Interventions

MPA; placebo

Participants

60

Sites

1

Countries

Canada

Trials that died the same way

• Use of Apheretic Technologies in Cardiovascular Disease
  “Funding missing” (71% match in meaning)
• Brain Stimulation and Rehabilitation for Adults With Chronic, Severe Arm Motor Impairment After Stroke
  “Ran out of funds” (67% match in meaning)
• Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia
  “funding became unavailable” (67% match in meaning)
• Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma
  “Funding has become unavailable” (64% match in meaning)
• Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy
  “no longer had funding to continue” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.